Why Migraine Sufferers May Want to Eat More Fish

A diet high in omega-3s, the fats found in fish, and low in omega-6s, found in many vegetable oils, led to fewer headaches.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Oils and Fats Migraine Headaches Diet and Nutrition Omega-3 Fatty Acids Seafood Pain BMJ (Journal) ' Connor, Anahad Source Type: news

Related Links:

Orbit. 2021 Sep 20:1-4. doi: 10.1080/01676830.2021.1974056. Online ahead of print.ABSTRACTThe current case report describes acute unilateral vision loss and bilateral cerebral infarction as devastating complications following cosmetic injection of hyaluronic acid to the nasal bridge in a 34-year-old female. The patient reported the onset of sudden eye pain, headache, and vision loss in her right eye. At the initial visit to the hospital, the patient had no light perception in the right eye. Examinations revealed marked ptosis and complete ophthalmoplegia with no proptosis. At the time of the patient's hospital evaluation, ...
Source: Orbit - Category: Opthalmology Authors: Source Type: research
ConclusionsDespite the low responder rate, CGRP antibodies can be effective at least in a few cases of severely affected patients with drug resistant migraine and chronic daily headache.Trial registrationRetrospective registered.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced a new analysis from the CHRYSALIS (NCT02609776) study evaluating RYBREVANT® (amivantamab-vmjw) monotherapy and a combination regimen with lazertinib in advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations who progressed after osimertinib.[1] The analysis showed higher activity and longer duration of response (DOR) in patients treated with the combination therapy, demonstrating the potential benefit of targeting the extracellular (outer) and cataly...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
This study aimed to assess the outcome and benefits of septal quilting sutures in comparison to nasal packing after septoplasty. A prospective non-randomized comparative interventional study was carried out at two teaching hospitals in Mosul city from January 2020 to January 2021. A total of 60 patients who were candidates for septoplasty, were included in the study. According to the surgeon's preference; 30 patients had placement of septal quilting sutures (group A), and in the other 30 patients nasal packing was performed (group B). Patients were assessed for postoperative morbidity and early outcome in the first 24 &nbs...
Source: Indian Journal of Otolaryngology and Head and Neck Surgery - Category: ENT & OMF Source Type: research
The majority of our knowledge of chronic pain in the general population comes from self-report studies. During the last three decades most of these population-based surveys have found that 20% to 35% of the general population suffer from chronic pain [4,6,10,22,23,25,27]. Globally, it is estimated that low back pain, migraine, neck pain, other musculoskeletal disorders, osteoarthritis, and tension type headache are rank numbered 1, 2, 6, 7, 12, and 28 with respect to causes of years lived with disability and that respectively 650, 850, 350, 250, 240, and 1560 million people worldwide suffer from these pain-related disorders [28].
Source: The Journal of Pain - Category: Materials Science Authors: Source Type: research
Source: Current Pain and Headache Reports - Category: Neurology Source Type: research
AbstractBackgroundOsmophobia, is common among primary headaches, with prevalence of migraine.The study aimed to evaluate prevalence and clinical characteristics of patients with osmophobia in a cohort of primary headache patients selected at a tertiary headache center. The second aim was to verify the possible predicting role of osmophobia in preventive treatment response in a sub cohort of migraine patients.MethodsThis was an observational retrospective cohort study based on data collected in a tertiary headache center.We selected patients aged 18 –65 years, diagnosed as migraine without aura (MO), migraine w...
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
ConclusionErenumab was associated with clinically relevant improvements in all efficacy endpoints and was well tolerated across all subgroups of Japanese migraine patients with/without prior preventive treatment failure(s) and with/without concomitant preventive treatment.Trial registrationClinicaltrials.gov. NCT03812224. Registered January 23, 2019.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5561-5577. doi: 10.26355/eurrev_202109_26669.ABSTRACTWe aimed this systematic review to analyze and review the currently available published literature related to long COVID, understanding its pattern, and predicting the long-term effects on survivors. We thoroughly searched the databases for relevant articles till May 2021. The research articles that met our inclusion and exclusion criteria were assessed and reviewed by two independent researchers. After preliminary screening of the identified articles through title and abstract, 249 were selected. Consequently, 167 full-text art...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Authors: Source Type: research
AbstractBackgroundHeadache is a frequent symptom following COVID-19 immunization with a typical onset within days post-vaccination. Cases of cerebral venous thrombosis (CVT) have been reported in adenovirus vector-based COVID-19 vaccine recipients.FindingsWe reviewed all vaccine related CVT published cases by April 30, 2021. We assessed demographic, clinical variables and the interval between the vaccination and onset of headache. We assessed whether the presence of headache was associated with higher probability of death or intracranial hemorrhage.We identified 77 cases of CVT after COVID-19 vaccination. Patients ’ ...
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
More News: Diets | Fish | Headache | Health | Migraine | Nutrition | Omega 3 | Pain | Seafood | Vegetables